Skip to main content
. 2021 Jan 11;11:586653. doi: 10.3389/fphar.2020.586653

FIGURE 7.

FIGURE 7

LINC-PINT suppressed EMT, tumor proliferation, and invasion by blocking Wnt/β-catenin signaling pathway in GBM. (A) Western blot assay for EMT markers N-cadherin and Vimentin and Wnt/β-catenin markers β-catenin, CD44, and TCF1/TCF7 detected in transfected U87 and LN229 cells with or without Wnt/β-catenin pathway activator LiCL (20 mmol/L, treated for 24 h). (B) Relevant expression level of LINC-PINT in transfected U87 and LN229 cells treated with or without LiCL was determined by qRT-PCR assay. (C) The cell viability of transfected U87 and LN229 cells treated with or without LiCL was detected by CCK8 assay. (D) The cell invasion ability of transfected U87 and LN229 cells treated with or without LiCL was detected by transwell assay. n.s., no significance. **p < 0.01, ***p < 0.001, ****p < 0.0001.